…one oesophageal biopsy, and 2.1% (5/235) later had histological EoE, reflecting potential missed diagnostic opportunities. Converse…
Browse by entity family
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentionsPopular entities in these results
Choose an entity to see the articles in which it was identified.
Matching articles
29,499 articles · page 427 of 2459…pared with Dominant Pattern analysis for identifying conclusive GORD defined by LA B, C and D oesophagitis, with higher sensitivity …
…gy were compared in patients with and without hEDS. Patients on opioids, liquid meals and without available 4-hour study data were excl…
… would have missed PCa in 13.0% (73/562) of patients, including csPCa in 11.4% (64/562) and would have underestimated GG in 13.3% (75…
…ntroduction CT041, a Claudin18.2-specific CAR-T cell therapy in gastrointestinal tumors, has demonstrated encouraging efficacy and a manageable safety …
…Background Upper abdominal cancers, comprising oesophageal, gastric, and pancreatic malignancies, …
…b 44.3%, Adalimumab 27.9%, Vedolizumab 13.1%, Ustekinumab 9.8%, Golimumab 3.3% and Risankizumab 1.6%.The mean [±SD] gestational age at tr…
… lean mass, physical function and muscle strength in women with breast cancer during and following primary treatment.Design Systematic review…
…igure 1Overall and sex-stratified Pancreatic adenocarcinoma and Type 2 Diabetes mellitus-related age-adjusted mortality rates per 1,000,000 in the United States…
…huge resource and cost implications. We share our experience of pancreatic cyst surveillance from a non-tertiary UK teaching hospital.Methods A…
…by the Specialist Dietitian, of which 65 (84%) patients were on Pancreatic Enzyme Replacement Therapy (PERT). 49 had a faecal elastase <20 (64%). 8 patients (10%) we…